Psyence Biomedical Ltd.
PBMWW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001985062
No open-market purchases or sales by Psyence Biomedical Ltd. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $121.6K in total; no superinvestor holds it.
Other share classesPBM
Q4 2024 vs. Q3 2024
How the institutions holding Psyence Biomedical Ltd. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 23 | 22 | −1 |
| Shares | 6.29M | 5.74M | −553.7K (−8.8%) |
| Value | $79.2K | $80.2K | +$937 (+1.2%) |
New holders (3)
Institutions that held Psyence Biomedical Ltd. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Harraden Circle Investments, LLC | 1,150,000 | $16.6K | 0.01% |
| LMR Partners LLP | 200,000 | $2.88K | 0.00% |
| Virtu Financial LLC | 50,551 | $1.00K | 0.00% |
Sold out (4)
Institutions that held Psyence Biomedical Ltd. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Cowen and Company, LLC | 1,220,986 | $15.4K |
| Context Capital Management, LLC | 234,200 | $2.95K |
| Shaolin Capital Management LLC | 148,809 | $1.88K |
| Anson Funds Management LP | 12,500 | – |